研究業績-2013｜糖尿病 食事療法 治療 京大病院 栄養内科
Takagi T, Furuta H, Miyawaki M, Nagashima K, Shimada T, Doi A, Matsuno S, Tanaka D, Nishi M, Sasaki H, Inagaki N, Yoshikawa N, Nanjo K, Akamizu T. Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitus. J Diabetes Investig. 2013 May 6;4(3):269-73. doi: 10.1111/jdi.12049. Epub 2013 Mar 11.
Hosokawa M, Hamasaki A, Nagashima K, Harashima S, Toyoda K, Fujita Y, Harada N, Nakahigashi Y, Fujimoto S, Inagaki N. Lack of goal attainment regarding the low-density lipoprotein cholesterol level in the management of type 2 diabetes mellitus. Intern Med. 2013;52(21):2409-15.
Kondo Y, Harada N, Sozu T, Hamasaki A, Yamane S, Muraoka A, Harada T, Shibue K, Nasteska D, Joo E, Sasaki K, Inagaki N. A hospital-based cross-sectional study to develop an estimation formula for 2-h post-challenge plasma glucose for screening impaired glucose tolerance. Diabetes Res Clin Pract. 2013 Aug;101(2):218-25. doi: 10.1016/j.diabres.2013.05.013. Epub 2013 Jun 24.
Yamazaki T, Yamori M, Asai K, Nakano-Araki I, Yamaguchi A, Takahashi K, Sekine A, Matsuda F, Kosugi S, Nakayama T, Inagaki N, Bessho K; Nagahama Study Collaboration Group.. Mastication and risk for diabetes in a Japanese population: a cross-sectional study. PLoS One. 2013 Jun 5;8(6):e64113. doi: 10.1371/journal.pone.0064113. Print 2013.
Overbeck TR, Hupfeld T, Krause D, Waldmann-Beushausen R, Chapuy B, Guldenzoph B, Aung T, Inagaki N, Schondube FA, Danner BC, Truemper L, Wulf GG. Intracellular ATP-binding cassette transporter A3 is expressed in lung cancer cells and modulates susceptibility to cisplatin and paclitaxel. Oncology. 2013;84(6):362-70. doi: 10.1159/000348884. Epub 2013 May 15.
Abudukadier A, Fujita Y, Obara A, Ohashi A, Fukushima T, Sato Y, Ogura M, Nakamura Y, Fujimoto S, Hosokawa M, Hasegawa H, Inagaki N. Tetrahydrobiopterin has a glucose-lowering effect by suppressing hepatic gluconeogenesis in an endothelial nitric oxide synthase-dependent manner in diabetic mice. Diabetes. 2013 Sep;62(9):3033-43. doi: 10.2337/db12-1242. Epub 2013 May 6.
Tanaka D, Nagashima K, Sasaki M, Funakoshi S, Kondo Y, Yasuda K, Koizumi A, Inagaki N. Exome sequencing identifies a new candidate mutation for susceptibility to diabetes in a family with highly aggregated type 2 diabetes. Mol Genet Metab. 2013 May;109(1):112-7. doi: 10.1016/j.ymgme.2013.02.010. Epub 2013 Feb 21.
Sasaki M, Fujimoto S, Sato Y, Nishi Y, Mukai E, Yamano G, Sato H, Tahara Y, Ogura K, Nagashima K, Inagaki N. Reduction of reactive oxygen species ameliorates metabolism-secretion coupling in islets of diabetic GK rats by suppressing lactate overproduction. Diabetes. 2013 Jun;62(6):1996-2003. doi: 10.2337/db12-0903. Epub 2013 Jan 24.
Joo E, Yamane S, Hamasaki A, Harada N, Matsunaga T, Muraoka A, Suzuki K, Nasteska D, Fukushima T, Hayashi T, Tsuji H, Shide K, Tsuda K, Inagaki N. Enteral supplement enriched with glutamine, fiber, and oligosaccharide attenuates experimental colitis in mice. Nutrition. 2013 Mar;29(3):549-55. doi: 10.1016/j.nut.2012.09.007. Epub 2012 Dec 28.
Ikeda K, Fujimoto S, Goto M, Yamada C, Hamasaki A, Ida M, Nagashima K, Shide K, Kawamura T, Inagaki N. A new equation to estimate basal energy expenditure of patients with diabetes. Clin Nutr. 2013 Oct;32(5):777-82. doi: 10.1016/j.clnu.2012.11.017. Epub 2012 Dec 2.
Suzuki K, Harada N, Yamane S, Nakamura Y, Sasaki K, Nasteska D, Joo E, Shibue K, Harada T, Hamasaki A, Toyoda K, Nagashima K, Inagaki N. Transcriptional regulatory factor X6 (Rfx6) increases gastric inhibitory polypeptide (GIP) expression in enteroendocrine K-cells and is involved in GIP hypersecretion in high fat diet-induced obesity. J Biol Chem. 2013 Jan 18;288(3):1929-38. doi: 10.1074/jbc.M112.423137. Epub 2012 Nov 28.
Harashima S, Fukushima T, Sasaki M, Nishi Y, Fujimoto S, Ogura M, Yamane S, Tanaka D, Harada N, Hamasaki A, Nagashima K, Nakahigashi Y, Seino Y, Inagaki N. Self-monitoring of blood glucose (SMBG) improves glycaemic control in oral hypoglycaemic agent (OHA)-treated type 2 diabetes (SMBG-OHA study). Diabetes Metab Res Rev. 2013 Jan;29(1):77-84. doi: 10.1002/dmrr.2363.
Saito M, Hayakawa A, Inagaki N, Matsuoka H. Development of novel cell lines of diabetic dysfunction model fit for cell-based screening tests of medicinal materials. Cytotechnology. 2013 Jan;65(1):105-18. doi: 10.1007/s10616-012-9466-x. Epub 2012 Jul 10.
